When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Anti-asthmatic agent - Wikipedia

   en.wikipedia.org/wiki/Anti-asthmatic_agent

   An anti-asthmatic agent, also known as an anti-asthma drug, refers to a drug that can aid in airway smooth muscle dilation to allow normal breathing during an asthma attack or reduce inflammation on the airway to decrease airway resistance for asthmatic patients, or both. The goal of asthmatic agents is to reduce asthma exacerbation frequencies ...

3. Beta2-adrenergic agonist - Wikipedia

   en.wikipedia.org/wiki/Beta2-adrenergic_agonist

   They are primarily used to treat asthma and other pulmonary disorders. Bronchodilators are considered an important treatment regime for chronic obstructive pulmonary disease (COPD) and are usually used in combination with short acting medications and long acting medications in a combined inhaler. [1] [2]

4. If You're Living With Asthma, Here's Every Single Treatment ...

   www.aol.com/youre-living-asthma-heres-every...

   Asthma is a clinical medical condition that almost always requires treatment with medication. However, there are ways you can help lessen the likelihood of an attack in the first place. Humidifier

5. Category:Antiasthmatic drugs - Wikipedia

   en.wikipedia.org/wiki/Category:Antiasthmatic_drugs

   These drugs are used for the treatment of asthma. They may be useful either in the treatment or prevention of asthma attacks. Subcategories.

6. Discovery and development of beta2 agonists - Wikipedia

   en.wikipedia.org/wiki/Discovery_and_development...

   This long duration of action made the treatment for severe asthma and COPD more convenient for the patients because it is inhaled twice a day. [1] In 2013 an extra long-acting β 2-agonist, vilanterol, was marketed. Its duration of action lasts for 24 hours which should improve patients' compliance and make the treatment more convenient. [2]

7. Long-acting beta-adrenoceptor agonist - Wikipedia

   en.wikipedia.org/wiki/Long-acting_beta...

   This second medication in this combination is the synthetic inhaled corticosteroid fluticasone furoate. This product was approved by the FDA in May 2013 as once-daily inhaled therapy for the treatment of chronic obstructive pulmonary disease (COPD) with umeclidinium bromide: Anoro Ellipta.